These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 23425253

  • 21. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I.
    Orv Hetil; 2006 Oct 22; 147(42):2011-20. PubMed ID: 17165600
    [Abstract] [Full Text] [Related]

  • 22. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy.
    Jiang D, Shu C, Zhang W, Sun L, Zhang M, He Y, Owen G, Jin W, He D, Deng X, Liu X.
    Virchows Arch; 2021 Feb 22; 478(2):231-240. PubMed ID: 32588133
    [Abstract] [Full Text] [Related]

  • 23. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
    Wright CM, Dent OF, Newland RC, Barker M, Chapuis PH, Bokey EL, Young JP, Leggett BA, Jass JR, Macdonald GA.
    Gut; 2005 Jan 22; 54(1):103-8. PubMed ID: 15591513
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy.
    Du C, Xue W, Li J, Cai Y, Gu J.
    Hum Pathol; 2012 Jul 22; 43(7):1061-7. PubMed ID: 22204710
    [Abstract] [Full Text] [Related]

  • 27. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 28. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Haag GM, Czink E, Ahadova A, Schmidt T, Sisic L, Blank S, Heger U, Apostolidis L, Berger AK, Springfeld C, Lasitschka F, Jäger D, von Knebel Doeberitz M, Kloor M.
    Int J Cancer; 2019 Apr 01; 144(7):1697-1703. PubMed ID: 30499151
    [Abstract] [Full Text] [Related]

  • 29. Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer.
    Benzoni E, Terrosu G, Bresadola V, Cerato F, Cojutti A, Milan E, Dado G, Bresadola F.
    Eur J Cancer Care (Engl); 2006 Jul 01; 15(3):286-92. PubMed ID: 16882126
    [Abstract] [Full Text] [Related]

  • 30. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3471-7. PubMed ID: 18846402
    [Abstract] [Full Text] [Related]

  • 31. Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
    Storojeva I, Boulay JL, Heinimann K, Ballabeni P, Terracciano L, Laffer U, Mild G, Herrmann R, Rochlitz C.
    Oncol Rep; 2005 Jul 01; 14(1):241-9. PubMed ID: 15944796
    [Abstract] [Full Text] [Related]

  • 32. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B, Qiu HZ, Xiao Y, Lin GL, Niu BZ, Zhang FQ, Hu K.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar 01; 11(2):124-7. PubMed ID: 18344077
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.
    Wright CM, Dent OF, Barker M, Newland RC, Chapuis PH, Bokey EL, Young JP, Leggett BA, Jass JR, Macdonald GA.
    Br J Surg; 2000 Sep 01; 87(9):1197-202. PubMed ID: 10971428
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Chromosomal instability in microsatellite-unstable and stable colon cancer.
    Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, Kakar S, Fridlyand J, Snijders AM, Albertson DG, Thibodeau SN, Waldman FM.
    Clin Cancer Res; 2006 Nov 01; 12(21):6379-85. PubMed ID: 17085649
    [Abstract] [Full Text] [Related]

  • 36. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG, Kodner IJ.
    Dis Colon Rectum; 2004 Jun 01; 47(6):825-31. PubMed ID: 15108025
    [Abstract] [Full Text] [Related]

  • 37. Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.
    Colombino M, Cossu A, Manca A, Dedola MF, Giordano M, Scintu F, Curci A, Avallone A, Comella G, Amoruso M, Margari A, Bonomo GM, Castriota M, Tanda F, Palmieri G.
    Ann Oncol; 2002 Sep 01; 13(9):1447-53. PubMed ID: 12196371
    [Abstract] [Full Text] [Related]

  • 38. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
    Kim GP, Colangelo LH, Wieand HS, Paik S, Kirsch IR, Wolmark N, Allegra CJ, National Cancer Institute.
    J Clin Oncol; 2007 Mar 01; 25(7):767-72. PubMed ID: 17228023
    [Abstract] [Full Text] [Related]

  • 39. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
    Emile SH, Horesh N, Garoufalia Z, Gefen R, Zhou P, Strassmann V, Wexner SD.
    Int J Colorectal Dis; 2024 Mar 28; 39(1):43. PubMed ID: 38538931
    [Abstract] [Full Text] [Related]

  • 40. Chemosensitivity and survival in gastric cancer patients with microsatellite instability.
    Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, Ohgaki K, Morita M, Maehara Y.
    Ann Surg Oncol; 2009 Sep 28; 16(9):2510-5. PubMed ID: 19565284
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.